NYSE:MET - Metlife Stock Price, Price Target & More

Metlife trades on the New York Stock Exchange (NYSE) under the ticker symbol "MET."

Metlife declared a quarterly dividend on Friday, July 6th. Stockholders of record on Monday, August 6th will be paid a dividend of $0.42 per share on Thursday, September 13th. This represents a $1.68 annualized dividend and a dividend yield of 3.78%. The ex-dividend date of this dividend is Friday, August 3rd. View Metlife's Dividend History.

Metlife declared that its Board of Directors has authorized a stock buyback plan on Tuesday, May 22nd 2018, which authorizes the company to repurchase $1,500,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 3.1% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company's management believes its shares are undervalued.

Metlife Inc (NYSE:MET) issued its earnings results on Wednesday, May, 2nd. The financial services provider reported $1.36 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $1.17 by $0.19. The financial services provider had revenue of $15.15 billion for the quarter, compared to the consensus estimate of $15.52 billion. Metlife had a return on equity of 8.70% and a net margin of 6.48%. The company's revenue was up .6% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.20 EPS. View Metlife's Earnings History.

17 brokerages have issued twelve-month target prices for Metlife's shares. Their predictions range from $47.00 to $78.00. On average, they expect Metlife's stock price to reach $56.60 in the next year. This suggests a possible upside of 27.4% from the stock's current price. View Analyst Ratings for Metlife.

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Metlife in the last year. There are currently 9 hold ratings and 8 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Metlife saw a decline in short interest during the month of June. As of June 29th, there was short interest totalling 12,020,672 shares, a decline of 28.9% from the June 15th total of 16,900,543 shares. Based on an average daily trading volume, of 7,086,353 shares, the days-to-cover ratio is presently 1.7 days. Approximately 1.4% of the company's stock are sold short. View Metlife's Current Options Chain.

Some companies that are related to Metlife include China Life Insurance (LFC), Prudential Public (PUK), AXA (AXAHY), Prudential Financial (PRU), Manulife Financial (MFC), SWISS RE Ltd/S (SSREY), AVIVA PLC/ADR (AVVIY), Sun Life Financial (SLF), HANNOVER RUECK/S (HVRRY), Legal & General Group (LGEN), AMP (AMP), Lincoln National (LNC), OLD Mut PLC/ADR (ODMTY), AEGON (AEG) and Torchmark (TMK).

News coverage about MET stock has trended somewhat positive on Tuesday, Accern Sentiment reports. The research group identifies positive and negative press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Metlife earned a media sentiment score of 0.09 on Accern's scale. They also gave media coverage about the financial services provider an impact score of 47.00 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Metlife's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BOARD OF DIRECTORS OF METLIFE INC (15.00%), Bank of Montreal Can (0.19%), NN Investment Partners Holdings N.V. (0.17%), Lodestar Investment Counsel LLC IL (0.04%), Gofen & Glossberg LLC IL (0.03%) and Fjarde AP Fonden Fourth Swedish National Pension Fund (0.02%). Company insiders that own Metlife stock include Christopher G Townsend, Frans Hijkoop, Gerald L Hassell, James M Kilts, Maria R Morris and Peter M Carlson. View Institutional Ownership Trends for Metlife.

MET stock was sold by a variety of institutional investors in the last quarter, including Bank of Montreal Can, Welch & Forbes LLC, Gofen & Glossberg LLC IL, Gateway Investment Advisers LLC, Cullinan Associates Inc., Franklin Street Advisors Inc. NC, Fjarde AP Fonden Fourth Swedish National Pension Fund and CENTRAL TRUST Co. View Insider Buying and Selling for Metlife.

MET stock was bought by a variety of institutional investors in the last quarter, including Howard Capital Management Inc., Capital One National Association, Farmers Trust Co., DAVENPORT & Co LLC, NN Investment Partners Holdings N.V., Addenda Capital Inc., State of Alaska Department of Revenue and IFM Investors Pty Ltd. Company insiders that have bought Metlife stock in the last two years include Gerald L Hassell and James M Kilts. View Insider Buying and Selling for Metlife.

Shares of MET can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of MET stock can currently be purchased for approximately $44.44.

Metlife has a market capitalization of $44.93 billion and generates $62.09 billion in revenue each year. The financial services provider earns $4.01 billion in net income (profit) each year or $4.50 on an earnings per share basis. Metlife employs 49,000 workers across the globe.

Metlife's mailing address is 200 Park Avenue, New York NY, 10166. The financial services provider can be reached via phone at 212-578-9500.